273 related articles for article (PubMed ID: 19842033)
41. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
[TBL] [Abstract][Full Text] [Related]
42. Clinical impact of false-negative sentinel lymph nodes in breast cancer.
Zavagno G; Del Bianco P; Koussis H; Artioli G; Carraro P; De Salvo GL; Mencarelli R; Belardinelli V; Marconato G; Nitti D
Eur J Surg Oncol; 2008 Jun; 34(6):620-5. PubMed ID: 17764888
[TBL] [Abstract][Full Text] [Related]
43. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
44. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
45. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.
Martin RC; Derossis AM; Fey J; Yeung H; Yeh SD; Akhurst T; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
Surgery; 2001 Sep; 130(3):432-8. PubMed ID: 11562666
[TBL] [Abstract][Full Text] [Related]
46. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
47. [Lymphatic mapping in axilla as possible prevention of lymphedema in breast cancer patients - first results of the anatomical study].
Pavlista D; Eliška O
Ceska Gynekol; 2012 Jun; 77(3):251-4. PubMed ID: 22779729
[TBL] [Abstract][Full Text] [Related]
48. Sentinel lymph node biopsy, axillary dissection and breast cancer: radiation oncologist's viewpoint.
Bansal M; Mohanti BK
Natl Med J India; 2002; 15(3):154-7. PubMed ID: 12186329
[TBL] [Abstract][Full Text] [Related]
49. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
Trials; 2013 Apr; 14():111. PubMed ID: 23782712
[TBL] [Abstract][Full Text] [Related]
50. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
51. Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy.
Boneti C; Badgwell B; Robertson Y; Korourian S; Adkins L; Klimberg V
Minerva Ginecol; 2012 Oct; 64(5):421-30. PubMed ID: 23018481
[TBL] [Abstract][Full Text] [Related]
52. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
[TBL] [Abstract][Full Text] [Related]
53. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
54. Prevention of secondary lymphedema.
Pissas A; Rzal K; Math ML; el Nasser M; Dubois JB
Ann Ital Chir; 2002; 73(5):489-92. PubMed ID: 12704988
[TBL] [Abstract][Full Text] [Related]
55. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
56. ARM: axillary reverse mapping - the need for selection of patients.
Gobardhan PD; Wijsman JH; van Dalen T; Klompenhouwer EG; van der Schelling GP; Los J; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2012 Aug; 38(8):657-61. PubMed ID: 22607749
[TBL] [Abstract][Full Text] [Related]
57. [The sentinel lymph node in cancer of the breast: clinical aspects].
Rouzier R; Travagli JP; Atallah D; Delaloge S; Marsiglia H; Mathieu MC; Lumbroso J; Garbay JR
Bull Cancer; 2003 Mar; 90(3):246-54. PubMed ID: 12801827
[TBL] [Abstract][Full Text] [Related]
58. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
59. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
60. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
